Headache and Migraine

Latest News

Atogepant Shows Superiority Over Topiramate for Migraine Prevention

June 18th 2025

Topline results from a phase 3 trial showed 64.1% of patients on atogepant achieved a 50% or greater reduction in mean monthly migraine days during months 4 to 6.

Prenatal Use of Triptans Does Not Increase Risk of Autism, ADHD in Children

By Ashley Gallagher

May 24th 2025

FDA Approves Dihydroergotamine as Auto Injectable for Migraine Treatment

By Ashley Gallagher

May 16th 2025

Data Show Association Between Seizure Medication and Reduction in Migraine

By Ashley Gallagher

March 5th 2025

Symbravo Shows Greater Migraine Improvement Compared With Oral CGRP Inhibitors

By Ashley Gallagher

February 24th 2025

Latest CME Events & Activities

Navigating Parkinson Disease: Innovative Approaches to Mitigate OFF Episodes

1.0 Credit / Neurology

The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of ...

1.0 Credit / Neurology

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Immunology, Neurology

Exploring Therapeutic Advances for Bipolar Disorder With Mixed Features and Anxious Distress: An Update for Ph...

2.0 Credits / Neurology, Psychiatry

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Setti...

1.25 Credits / Neurology

Addressing the Unmet Needs in the Management of Myasthenia Gravis: The Role of New and Emerging Therapies

1.5 Credits / Neurology

In-Depth Insights and Application in the Management of Immunoglobulin Therapy

1.0 Credit / Neurology, Immunology

Overview and Burden of Migraine

0.5 Credit / Neurology

The Evolving Treatment Landscape of Migraine

0.5 Credit / Neurology

The Role of the Pharmacist Migraine Management

0.5 Credit / Neurology

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry

PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

0.75 Credit / Oncology, Law

More News

Impel NeuroPharma Announces NDA Submission for Acute Migraine Treatment

Gabrielle Ientile

November 27th 2020

The pharmaceutical company has submitted a New Drug Application for dihydroergotamine mesylate for fast and lasting whole migraine relief in adults with and without aura.

Pharmacists Can Help Manage Migraines in Patients With Psychiatric Conditions

Frieda Wiley, PharmD

November 11th 2020

Add value by optimizing medications, decreasing pill burden.

Galcanezumab Improves Work Productivity, Health and Well-Being in Patients With Migraine

May 27th 2020

Results from a phase 3 study showed that galcanezumab-gnlm (Emgality, Eli Lilly) significantly improved work productivity and health and well-being between migraine attacks.

Evidence-Based Treatment for Pediatric Migraine Prevention

Christina Graley, MD;Christopher Oakley, MD

May 25th 2020

Migraine is one of the most common neurologic disorders in children and adolescents with a prevalence of 7.7%.

FDA OKs Celecoxib Oral Solution for Acute Migraine Treatment

Jennifer Barrett

May 7th 2020

Officials with the FDA have approved celecoxib oral solution 25 mg/mL (Elyxyb, Dr. Reddy’s Laboratories) for the acute treatment of migraine with or without aura in adults.